Business Development Manager
Todd Giardiello holds a Bachelor of Science in Microbiology from Kutztown University and has been a part of the Rockland team since 2008. Over the years, he has progressed through several key positions throughout the lab and project management, now excelling as a Business Development Manager for Rockland's Complex Therapy Solutions line of business. Todd combines a strong scientific background with strategic insights to support our partners. Beyond his professional pursuits, Todd enjoys playing sports and building with Lego.
Articles
-
New Tools to Quantify and Localize ASOs and siRNAs
Discover ModDetect™: advanced tools for precise quantification and localization of modified oligonucleotides, enhancing RNA-based therapeutic research. -
The Utility of Antibodies When Investigating SARS-CoV-2 and Variants of Concern
This white paper discusses the drawbacks of monoclonal antibodies and the benefits of polyclonal antibodies in infectious disease detection. -
Robust Methods for Anti-Oligonucleotide Antibody Generation
In this poster we summarize our expertise in developing oligo-specific antibody reagents to a number of different target chemistries. -
Evaluation of Novel High-Coverage Generic CHO-HCP Reagents
Here we evaluate and demonstrate improved coverage of a new generic CHO-HCP reagent developed at Rockland. -
Lyme Disease: The Situation & Solution
Our solution engages the evasive nature of B. burgdorferi and the different bacterial phases and allows for the detection of the unique response of each patient -
Localization and Quantification of Oligonucleotide Therapeutic Drugs
This poster presents the development of universal detection reagents specific for nucleic acid modifications.